To boost the chances of recouping the cost of innovation bets, pharma companies must leverage a multi-pronged strategy that includes picking winning medicines, using technologies like AI and bringing the right external assets into the clinical fold.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to our use of all cookies, however, you may visit “Cookies Setting” to provide a controlled consent.

Privacy Policy